Table 3.
Pre–post changes in biomarkers of inflammation and glyco-lipo-oxidation compared between the two groups.
| MD + Curcumin/BSE | MD | p † | |
|---|---|---|---|
| hs-CRP (mg/L) | 0.10 ± 0.2 | 0.24 ± 0.54 | ns |
| NEFA (mmol/L) | −0.36 ± 0.61 | −0.79 ± 0.89 | ns |
| sRAGE (pg/mL) | −147.23 ± 109.02 | −118.13 ± 117.01 | ns |
| AGE (µg/mL) | −11.59 ± 12.49 | 0.15 ± 2.30 | <0.001 |
| MDA (µmol/L) | −0.10 ± 0.06 | −0.07 ± 0.03 | <0.02 |
| IL−6 (pg/mL) | −0.07 ± 35.18 | 18.13 ± 59.73 | ns |
| TNFα (pg/mL) | 0.99 ± 6.88 | 5.62 ± 11.14 | ns |
NEFA: non-esterified fatty acids; sRAGE: soluble receptor for advanced glycation end products; AGE: advanced glycation end products; MDA: malondialdehyde; IL-6: interleukine-6; TNFα: tumor necrosis factor α; hsCRP: c-reactive protein. Variables are presented as the mean (±SD) change from baseline. † Data were compared using Student’s t-test for unpaired data. ns: not statistically significant.